ロード中...
A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII
Adenovirus (Ad) is thought to be one of the most promising platforms for a malaria vaccine targeted against its liver stages, because of its ability to induce a strong T-cell response against a transgene. However, a further improvement of this platform is needed in order to elicit another arm of the...
保存先:
| 出版年: | Vaccine |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5709203/ https://ncbi.nlm.nih.gov/pubmed/29089194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2017.10.066 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|